Sign in

CIK 0001023024

  • Large accelerated filer

ANI PHARMACEUTICALS INC

Sign in to watch
Ticker
ANIP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
582301143
Phone
+1 609-759-1810
Business address
104 CARNEGIE CENTER DRIVE SUITE 300, PRINCETON, NJ, 08540
Former names
BIOSANTE PHARMACEUTICALS INC, BEN ABRAHAM TECHNOLOGIES INC
  1. 4 Grant or award Director acquired 1,000 shares (grant or award)
  2. 4 Grant or award Director acquired 1,000 shares (grant or award)
  3. 4 Grant or award SVP - New Bus Dev & Spec Sales acquired 6,625 shares (grant or award)
  4. 4 Grant or award President and CEO acquired 23,750 shares (grant or award)
  5. 4 Grant or award SVP Ops & Prod Dev acquired 3,625 shares (grant or award)
  6. 4 Grant or award Vice President and CFO acquired 6,625 shares (grant or award)
  7. 4 Exercise or conversion Director acquired 5,458 shares (option exercise)
  8. 4 Open-market sale President and CEO sold 37,455 shares at $66.97 ($2,508,361)
  9. 4 Open-market sale VP Bus Dev & Con Mfg sold 12,500 shares at $67.06 ($838,209)
  10. 4 Gift President and CEO gave 836 shares (gift)
  11. 4 Shares withheld for taxes President and CEO gave up 991 shares (to pay taxes)
  12. 4 Shares withheld for taxes VP Bus Dev & Con Mfg gave up 450 shares (to pay taxes)
  13. 4 Derivatives Options or other derivatives
  14. 3 Insider Initial Statement of Ownership
  15. 4 Shares withheld for taxes President and CEO gave up 1,161 shares (to pay taxes)
  16. 4 Grant or award Director acquired 1,000 shares (grant or award)
  17. 4 Grant or award Director acquired 1,000 shares (grant or award)
  18. 4 Grant or award Vice President and CFO acquired 4,200 shares (grant or award)
  19. 4 Grant or award Director acquired 1,000 shares (grant or award)
  20. 4 Grant or award Director acquired 1,000 shares (grant or award)

Page 24 of 42 · 835 filings